Evidence map›Paper›PMID 27266969›Full record

ReviewCurrent opinion in genetics & development2016

Regeneration of pancreatic insulin-producing cells by in situ adaptive cell conversion.

Simona Chera, Pedro L Herrera

Open access · bronzeAbstract readReview
In one paragraph

Review in Current opinion in genetics & development, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Regenerative medicine of pancreatic islets.World journal of gastroenterology · 2020
    Review
  11. Frontiers in cell and developmental biology · 2020
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Disease models & mechanisms · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Simona CheraDepartment of Clinical Science, Faculty of Medicine and Dentistry, University of Bergen, Jonas Lies vei 65, 5021 Bergen, Norway.
Pedro L HerreraDepartment of Genetic Medicine & Development, Faculty of Medicine, Institute of Genetics and Genomics in Geneva (iGE3), and Centre facultaire du diabète, University of Geneva, 1 rue Michel-Servet, 1211 Geneva-4, Switzerland. Electronic address: pedro.herrera@unige.ch.
University of Bergen · NOUniversity of Geneva · CH

Funding

Beta-cell Regeneration by Islet Cell Type Interconversion: Exploiting Islet Cell Plasticity for Diabetes RecoveryUC4DK104209 · NIDDK · UNIVERSITY OF GENEVA · PI HERRERA, PEDRO L · 2014 to 2014
$2.4M
TRANSGENIC MODEL OF INDUCIBLE DIABETESU01DK072522 · NIDDK · UNIVERSITY OF GENEVA · PI HERRERA, PEDRO L · 2005 to 2009
$1.5M
Beta Cell Regeneration by Reprogramming of Adult Pancreatic CellsU01DK089566 · NIDDK · UNIVERSITY OF GENEVA · PI HERRERA, PEDRO L · 2010 to 2014
$1.0M
NIDDK NIH HHS U01 DK072522NIDDK NIH HHS U01 DK089566NIDDK NIH HHS UC4 DK104209
6 · The paper itself

Abstract

The impaired ability to produce or respond to insulin, a hormone synthetized by the pancreatic β-cells, leads to diabetes. There is an excruciating need of finding new approaches to protect or restore these cells once they are lost. Replacement and ex vivo directed reprogramming methods have an undeniable therapeutic potential, yet they exhibit crucial flaws. The in vivo conversion of adult cells to functional insulin-producing cells is a promising alternative for regenerative treatments in diabetes. The stunning natural transdifferentiation potential of the adult endocrine pancreas was recently uncovered. Modulating molecular targets involved in β-cell fate maintenance or in general differentiation mechanisms can further potentiate this intrinsic cell plasticity, which leads to insulin production reconstitution.

Indexed as

AnimalsCell PlasticityCell TransdifferentiationCellular ReprogrammingDiabetes MellitusHumansInsulinInsulin-Secreting CellsRegenerationInsulin

Identifiers

PMID27266969
PMCPMC5135655
OpenAlexW2413758991

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.